UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (6) 6
science & technology (6) 6
female (5) 5
humans (5) 5
male (5) 5
obesity (5) 5
body mass index (4) 4
obesity - drug therapy (4) 4
risk factors (4) 4
adult (3) 3
double-blind method (3) 3
internal medicine (3) 3
middle aged (3) 3
weight loss (3) 3
weight loss - drug effects (3) 3
abridged index medicus (2) 2
adolescent (2) 2
body weight - drug effects (2) 2
body weight loss (2) 2
cardiology (2) 2
child (2) 2
clinical trials (2) 2
diabetes mellitus (2) 2
endocrinology (2) 2
evidence-based medicine (2) 2
exercise (2) 2
food and nutrition (2) 2
general & internal medicine (2) 2
glucagon-like peptide 1 - analogs & derivatives (2) 2
human health and pathology (2) 2
hypertension (2) 2
hypoglycemic agents - administration & dosage (2) 2
hypoglycemic agents - adverse effects (2) 2
injections, subcutaneous (2) 2
life sciences (2) 2
liraglutide - administration & dosage (2) 2
liraglutide - adverse effects (2) 2
liraglutide - pharmacology (2) 2
medicine (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
obesity - epidemiology (2) 2
obesity - ethnology (2) 2
oncology (2) 2
pharmacology/toxicology (2) 2
rheumatology (2) 2
weight control (2) 2
adult; blood glucose; body mass index; combined modality therapy; counseling; diarrhea; diet, reducing; double-blind method; exercise; female; glucagon-like peptide 1; humans; hypoglycemic agents; injections, subcutaneous; liraglutide; male; middle aged; nausea; obesity; weight loss; medicine (1) 1
alcohol (1) 1
analysis (1) 1
anthropometry (1) 1
appetite depressants - adverse effects (1) 1
appetite depressants - therapeutic use (1) 1
autoimmune diseases (1) 1
back pain (1) 1
biological and medical sciences (1) 1
blood glucose (1) 1
blood glucose - analysis (1) 1
blood glucose - drug effects (1) 1
blood glucose - metabolism (1) 1
blood pressure - drug effects (1) 1
body fat (1) 1
body height - physiology (1) 1
body weight (1) 1
body weight - physiology (1) 1
bolivia (1) 1
cardiac arrest (1) 1
cardiovascular diseases (1) 1
cardiovascular risk factors (1) 1
charts (1) 1
children & youth (1) 1
classification (1) 1
clinical medicine (1) 1
combined modality therapy (1) 1
comorbidity (1) 1
counseling (1) 1
cross-sectional studies (1) 1
cyclobutanes - adverse effects (1) 1
cyclobutanes - therapeutic use (1) 1
demographic aspects (1) 1
diabetes (1) 1
diabetes mellitus, type 2 - diagnosis (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diabetes therapy (1) 1
diagnosis (1) 1
diarrhea (1) 1
diarrhea - chemically induced (1) 1
diet, reducing (1) 1
dosage and administration (1) 1
drug therapy (1) 1
dyslipidemia (1) 1
endocrinology & metabolism (1) 1
evaluation (1) 1
folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (1) 1
gallbladder diseases (1) 1
gastrointestinal surgery (1) 1
glucagon (1) 1
glucagon-like peptide 1 (1) 1
glucagon-like peptide 1 - administration & dosage (1) 1
glucagon-like peptide 1 - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 1, pp. 11 - 22
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10077, pp. 1399 - 1409
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Obesity - drug therapy | Glucagon-Like Peptide-1 Receptor - administration & dosage | Humans | Middle Aged | Body Weight - drug effects | Male | Weight Loss - drug effects | Liraglutide - pharmacology | Injections, Subcutaneous | Adult | Female | Placebos - administration & dosage | Body Mass Index | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Risk Reduction Behavior | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Glucagon-Like Peptide 1 - pharmacology | Prediabetic State - prevention & control | Treatment Outcome | Prediabetic State - complications | Blood Glucose - drug effects | Prediabetic State - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Liraglutide - adverse effects | Obesity - epidemiology | Placebos - pharmacology | Incretins - therapeutic use | Liraglutide - administration & dosage | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Type 2 diabetes | Clinical trials | Glucose metabolism | Risk factors | Prediabetic state | Diabetes therapy | Exercise | Obesity | Evaluation | Diabetes mellitus | Health risks | Weight loss | Glucose | Evidence-based medicine | Studies | Weight control | Randomization | Immunology | Classification | Weight reduction | Gastrointestinal surgery | Diabetes | Clinical medicine | Diagnosis | Autoimmune diseases | Risk management | Back pain | Physical activity | Gallbladder diseases | Body weight loss | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Hypertension | Risk reduction | Metabolism | Investigations | Nutrition research | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.